CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 14,402 Value ($000) $736 Avg Close $55.95 Range $49.48 - $62.53

Q3 2024

Shares 41,558 Value ($000) $2,124 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 42,336 Value ($000) $1,896 Avg Close $46.18 Range $41.01 - $53.70

Q1 2024

Shares 29,000 Value ($000) $1,357 Avg Close $39.13 Range $33.67 - $47.58

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	14,402	$736	$55.95	$49.48 - $62.53
Q3 2024	41,558	$2,124	$51.57	$43.71 - $55.78
Q2 2024	42,336	$1,896	$46.18	$41.01 - $53.70
Q1 2024	29,000	$1,357	$39.13	$33.67 - $47.58